Cleveland Cord Blood Center receives FDA biologics license for stem cell product – Crain’s Cleveland Business
|
Cleveland Cord Blood Center receives FDA biologics license for stem cell product
Crain’s Cleveland Business The Cleveland Cord Blood Center announced it has been issued a biologics license from the U.S. Food and Drug Administration for CLEVECORD, a stem cell product derived from umbilical cord blood. With the license, the Cord Blood Center said in a news … |
